The science behind wound healing seems to grow more complex by the day. Advancements in molecular biology and medical device technology are making innovative wound healing products possible that were otherwise unimaginable even a few short years ago. Of course, the more groundbreaking a potential wound healing product is, the greater the need becomes for a qualified contract research organization (CRO) capable of analyzing tissue samples in a timely, efficient manner.
StageBio is growing! Interested in joining our team? We are currently hiring for positions all across the company, including pathologists, scientists and technicians.
StageBio is excited to introduce you to our new Director of Digital and Quantitative Pathology, our very own Dr. Thomas Lemarchand!
StageBio recently hosted the webinar, Successful Virtual Necropsy and Specimen Study Logistics.
It is with great honor that we introduce Dr. Serge Rousselle as StageBio’s Chief Scientific Officer. Dr. Rousselle is the co-founder of Alizee Pathology (now part of StageBio) a world-renowned veterinary pathologist with special interest in digital pathology and image analysis.
The StageBio team is looking forward to attending the 2021 Society of Toxicology’s Annual Meeting and ToxExpo this month - and we hope to see you there!
Dr. Deepa Rao, Veterinary Toxicologic Pathologist at StageBio, has been elected Councilor on the Executive Committee of the Society of Toxicologic Pathology.
StageBio Virtual Necropsy & Courier/Archiving Solutions Reduce Timelines!
StageBio expands its global presence with acquisition of TPL Path Labs
StageBio Announces Opening of New Facility in Greater Boston Area
513.204.4400
